Get the Stockscreener App
1.1447
4.55%
0.0447
Tenaya Therapeutics Inc stock is traded at $1.1447, with a volume of 423.27K.
It is up +4.55% in the last 24 hours and up +47.45% over the past month.
Tenaya Therapeutics Inc is a preclinical stage biotechnology company focused on discovering, developing, and delivering curative therapies that address the underlying drivers of heart disease. It is advancing product candidates from three product platforms: gene therapy, cellular regeneration and precision medicine.
See More
Previous Close:
$1.10
Open:
$1.11
24h Volume:
423.27K
Relative Volume:
0.14
Market Cap:
$186.61M
Revenue:
-
Net Income/Loss:
$-111.13M
P/E Ratio:
-0.8672
EPS:
-1.32
Net Cash Flow:
$-91.53M
1W Performance:
-0.86%
1M Performance:
+47.45%
6M Performance:
+13.86%
1Y Performance:
-56.60%
1-Day Range:
$1.11
$1.1601
1-Week Range:
$1.05
$1.21
52-Week Range:
$0.36
$4.01
Tenaya Therapeutics Inc Stock (TNYA) Company Profile
Name
Tenaya Therapeutics Inc
Sector
Industry
Phone
415-865-2066
Address
171 OYSTER POINT BLVD., SUITE 500, SOUTH SAN FRANCISCO
Compare TNYA with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
TNYA
Tenaya Therapeutics Inc
|
1.145 | 176.01M | 0 | -111.13M | -91.53M | -1.32 |
|
VRTX
Vertex Pharmaceuticals Inc
|
389.04 | 99.27B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
581.20 | 62.28B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
452.16 | 59.14B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
698.97 | 43.34B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
297.29 | 36.72B | 3.81B | -644.79M | -669.77M | -6.24 |
Tenaya Therapeutics Inc Stock (TNYA) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jun-10-24 | Initiated | William Blair | Outperform |
| Nov-30-23 | Initiated | Leerink Partners | Outperform |
| Jun-15-22 | Initiated | H.C. Wainwright | Buy |
Tenaya Therapeutics Inc Stock (TNYA) Latest News
Short interest data insights for Tenaya Therapeutics Inc.Weekly Profit Analysis & Stock Portfolio Risk Management - Newser
Tenaya Therapeutics Inc.’s volatility index tracking explainedEarnings Recap Summary & Reliable Price Action Trade Plans - Newser
Earnings visualization tools for Tenaya Therapeutics Inc.2025 Investor Takeaways & Weekly Chart Analysis and Guides - Newser
Best data tools to analyze Tenaya Therapeutics Inc. stock2025 Historical Comparison & Accurate Intraday Trade Tips - Newser
What earnings revisions data tells us about Tenaya Therapeutics Inc.2025 Price Momentum & AI Based Trade Execution Alerts - Newser
Signal strength of Tenaya Therapeutics Inc. stock in tech scannersWeekly Stock Recap & Weekly High Momentum Picks - Newser
Tenaya Therapeutics Inc. stock trend forecastIPO Watch & Free Fast Gain Swing Trade Alerts - Newser
Can Tenaya Therapeutics Inc. hit a new high this monthJuly 2025 Price Swings & Expert Curated Trade Setup Alerts - Newser
Tenaya Therapeutics Inc. stock momentum explainedPortfolio Value Summary & Daily Stock Trend Watchlist - Newser
Volume spikes in Tenaya Therapeutics Inc. stock – what they mean2025 Buyback Activity & Free Long-Term Investment Growth Plans - Newser
Why Tenaya Therapeutics Inc. is moving todayJuly 2025 Momentum & Daily Chart Pattern Signals - Newser
Will Tenaya Therapeutics Inc. see short term momentum2025 Big Picture & Fast Gain Swing Alerts - Newser
Live market analysis of Tenaya Therapeutics Inc.2025 Historical Comparison & Weekly Setup with High ROI Potential - Newser
Long term hold vs stop loss in Tenaya Therapeutics Inc.Portfolio Profit Report & Reliable Price Breakout Alerts - Newser
Is this a good reentry point in Tenaya Therapeutics Inc.Quarterly Earnings Report & Long-Term Capital Growth Strategies - Newser
What analysts say about Tenaya Therapeutics Inc. stock outlookMarket Activity Recap & Long-Term Growth Portfolio Plans - Newser
Assessing Tenaya Therapeutics' Strategic Momentum Ahead of Key 2025 Milestones - AInvest
Moving Average Crossover Confirms Uptrend in Tenaya Therapeutics Inc. getLinesFromResByArray error: size == 0 - newsyoung.net
Detecting support and resistance levels for Tenaya Therapeutics Inc.July 2025 Breakouts & Reliable Price Breakout Alerts - Newser
Volatility clustering patterns for Tenaya Therapeutics Inc.Gold Moves & Daily Entry Point Alerts - Newser
Can Tenaya Therapeutics Inc. reach all time highs this yearEarnings Summary Report & Fast Gaining Stock Strategy Reports - theviewers.co.kr
What technical models suggest about Tenaya Therapeutics Inc.’s comeback2025 Breakouts & Breakdowns & Free Reliable Trade Execution Plans - Newser
Will Tenaya Therapeutics Inc. stock go up soonSwing Trade & Risk Managed Investment Strategies - Newser
News impact scoring models applied to Tenaya Therapeutics Inc.Weekly Investment Report & AI Optimized Trade Strategies - Newser
Is Tenaya Therapeutics Inc. forming a reversal patternJuly 2025 Market Mood & Stepwise Swing Trade Plans - Newser
Is a relief rally coming for Tenaya Therapeutics Inc. holdersPortfolio Value Report & Technical Pattern Alert System - Newser
Is Tenaya Therapeutics Inc. attractive for institutional investors2025 Technical Overview & Technical Entry and Exit Alerts - theviewers.co.kr
Is It Too Early to Call Recovery in Tenaya Therapeutics Inc.Weekly Investment Summary & Reliable Volume Spike Trade Alerts - 더경남뉴스
How to read the order book for Tenaya Therapeutics Inc.Weekly Trade Review & Capital Efficiency Focused Strategies - Newser
Published on: 2025-08-23 01:15:10 - Newser
RSI + MACD Show Convergence for Tenaya Therapeutics Inc.July 2025 Selloffs & Daily Chart Pattern Signal Reports - beatles.ru
Moving Average Crossover Confirms Uptrend in Tenaya Therapeutics Inc.2025 Analyst Calls & Intraday High Probability Alerts - newsyoung.net
Measuring Tenaya Therapeutics Inc.’s beta against major indicesQuarterly Portfolio Summary & Weekly High Return Stock Opportunities - Newser
Tenaya Therapeutics Inc. Could See a Relief Rally From SupportWeekly Gains Report & Free Expert Approved Momentum Trade Ideas - beatles.ru
Tenaya Therapeutics’ Innovative Endeavors Spark Investor Interest - timothysykes.com
Tenaya: Two Heart Disorder Data Releases Q4 2025 Brings About Major Inflection Point - Seeking Alpha
Tenaya Therapeutics Inc Stock (TNYA) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.33%
0.61%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):